Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1424042Generated: November 1, 2026

Potassium Phosphate, Tribasic → (8R)-8-({[t-Butyl(dimethyl)silyl]oxy}methyl)-8-methyl-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepine

https://huagongshe.com/reaction/1424042

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPotassium Phosphate, TribasicHCID 62657—
ReactantTricyclohexylphosphineHCID 75806—
Reactant1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazoleHCID 2773987—
Reactant(8R)-8-({[t-Butyl(dimethyl)silyl]oxy}methyl)-3-[1-(4-chlorophenyl)cyclopropyl]-8-methyl-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepineHCID 86712840—
CatalystBis(dibenzylideneacetone)palladiumHCID 9811564—
SolventWaterHCID 962—
SolventDichloromethaneHCID 6344—
Solvent1,4-DioxaneHCID 31275—
Product(8R)-8-({[t-Butyl(dimethyl)silyl]oxy}methyl)-8-methyl-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]cyclopropyl}-5,6,8,9-tetrahydro[1,2,4]triazolo[4,3-d][1,4]thiazepineHCID 86712892100.9%

Reaction Conditions

Temperature140 °C

Reaction Steps

The compound (255 mg, 0.55 mmol) obtained in Example 4-2), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (126 mg, 0.60 mmol), tris(dibenzylideneacetone)dipalladium (25 mg, 0.03 mmol), tricyclohexylphosphine (29 mg, 0.07 mmol), and tripotassium phosphate (205 mg, 0.93 mmol) were dissolved in a mixed solvent of 1,4-dioxane (2 mL) and water (1 mL), and the mixture was stirred at 140° C. for 2 h under microwave irradiation. The reaction mixture was cooled to room temperature, then diluted with methylene chloride (60 mL), and separated into organic and aqueous layers by the addition of saturated aqueous sodium hydrogencarbonate (20 mL). The organic layer was washed with saturated sodium chloride solution and then dried with anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (elution solvent: methanol/ethyl acetate=0% to 20%) to obtain the title compound (283 mg, quant.) in a colorless solid form.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08927536B2
Source datasetuspto-grants-2015_01
ORD IDord-8ccb4851b90d4cbaaa23749d94df6fb0
Source noteuspto-grants-2015_01